Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study.

BACKGROUND: Limited data are available regarding antiviral therapy efficacy in most severe patients under mechanical ventilation for Covid-19-related acute respiratory distress syndrome (ARDS). METHODS: Comparison of antiviral strategies (none, hydroxychloroquine (OHQ), lopinavir/ritonavir (L/R), others (combination or remdesivir) in an observational multicentre cohort of patients with moderate-to-severe Covid-19 ARDS. The primary endpoint was the number of day 28 ventilator-free days (VFD). Patients who died before d28 were considered as having 0 VFD. The variable was dichotomized into "patie... Mehr ...

Verfasser: Grimaldi, David
Aissaoui, Nadia
Blonz, Gauthier
Carbutti, Giuseppe
Courcelle, Romain
Gaudry, Stephane
Gaultier, Aurelie
D'hondt, Alain
Higny, Julien
Horlait, Geoffrey
Hraiech, Sami
Lefebvre, Laurent
Lejeune, Francois
Ly, Andre
Piagnerelli, Michael
Sauneuf, Bertrand
Serck, Nicolas
Soumagne, Thibaud
Szychowiak, Piotr
Textoris, Julien
Vandenbunder, Benoit
Vinsonneau, Christophe
Lascarrou, Jean- Baptiste
COVADIS study group
Dokumenttyp: Artikel
Erscheinungsdatum: 2020
Verlag/Hrsg.: Springer-Verlag
Schlagwörter: Acute kidney injury / Hydroxychloroquine / Lopinavir / Remdesivir / Renal replacement therapy / Ritonavir
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27305522
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2078.1/237328